Moneycontrol
HomeNewsBusinessNHAI plans to bid out more public private partnership projects through BOT route: Sources
Trending Topics

NHAI plans to bid out more public private partnership projects through BOT route: Sources

In the current financial year, NHAI had initially planned to award 450 km of road projects through the BOT model but is likely to exceed its set target, one company official said, with 15-20 percent of total projects being under this mode in 2022-23.

November 12, 2021 / 16:41 IST
Story continues below Advertisement
Representative image

As part of its plans to generate revenue from assets worth Rs 1.6 lakh crore in the next four years, the National Highways Authority of India (NHAI) is looking to come out with more tenders under the build-operate-transfer (BOT) model, which can be then monetized after two years, senior NHAI officials told Moneycontrol.

In the current financial year, NHAI had initially planned to award 450 km of road projects through the BOT model but is likely to exceed its set target, one company official said, with 15-20 percent of total projects being under this mode in 2022-23.

Story continues below Advertisement

As part of its plans, NHAI is looking to bid out around 600-1,000 km highway stretches in 2022-23 through the BOT model after seeing renewed interest from investors in 2021-22, sources said.

In 2021-22, BOT projects made up less than 10 percent of all projects awarded, with engineering, procurement and construction (EPC) contracts and the hybrid annuity model (HAM) projects accounting for the most.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show